View Author
scopus: 14033813500

Coleman, L.

(Leslie Coleman)


stent patient group target restenosi month revascularization follow-up trial vessel diameter angiographic des patients actinomycin target site revascularization table performance end points difference study 0.58 drug-eluting control ͻ0.001 action des groups 12 months safety 6 months 2.5 30 days artery serruy point ms group intravascular lesion infarction stenosi baseline ultrasound randomized diameter stenosis value ms patients american college outcome ivus fi ndings hospital event ivus follow-up death value ϯ sd germany performance characteristic netherland nding result neointimal australia signi end points segment stent apposition in-stent 28 days lumen loss october angiographic characteristics cardiology 0.05 sao paulo sample size log-rank tests angiography signi ficantly ef ficacy reference drug-eluting stents target site




1 Most Recent Publications

Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial. (Article)
Serruys, P.W.J.C. Ormiston, J.A. Thuesen, L. Zeiher, A.M. Bett, J.H. Suttorp, M.J. Glogar, H.D. Pitney, M. Wilkins, G.T. Whitbourn, R. Veldhof, S. Miquel, K. Sianos, G. Johnson, R. Coleman, L. Virmani, R. Feyter, P.J. de Sousa, J.E. Grube, E. Heijer, P. den Buszman, P. Schomig, A. Marco, J. Polonski, L.
2004-10-06